Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3997057 | Revista Colombiana de Cancerología | 2016 | 12 Pages |
Abstract
Vaccination against HPV reduces the costs of controlling uterine cervical cancer, but it requires a sustained investment for a long period of time. The reduction in the vaccine and screening costs would bring significant economic benefits, where the new, alternative technologies could play an important role.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Oscar Gamboa, Raúl Murillo,